Profile: Geoffrey Joyce
Assoc. Prof. of Pharmaceutical Economics
Geoffrey Joyce is an Associate Professor of Pharmaceutical Economics at the University of Southern California, Director of Health Policy at the Leonard D. Schaeffer Center, Research Associate at the National Bureau of Economic Research, and a director of AHRQs Postdoctoral Training Program.
Dr. Joyce is the author of over 70 articles and book chapters, and his research has been published in leading medical, economic, health policy and statistics journals. Dr. Joyce’s work has been featured in the Wall Street Journal, Washington Post, Los Angeles Times, U.S. News and World Report, NBC Nightly News, CBS Evening News, National Public Radio, and other media.
NoteStreams By Geoffrey Joyce
More than eight out of every 10 prescriptions dispensed in the US is generic. This growth is due to a large number of top-selling drugs going off patent over the past decade, as well as innovations in the retail sector, such as Walmart’s US$4 generic program. Over this period, generic drug prices declined or held steady, saving American consumers tens of billions of dollars annually. But recently prices of some long-time generic drugs like digoxin (a heart medication), albuterol (for asthma) and doxycycline (an antibiotic) increased more than ten-fold over a very short period of time. This has prompted the Senate subcommittee on health and aging to investigate why prices for some generic drugs have risen so high, so fast.